Quantcast
Last updated on June 2, 2012 at 19:02 EDT

News - Curtis Wright

2005-09-07 18:01:08

Javelin Pharmaceuticals, Inc. (OTC BB: JVPH) has named Curtis Wright, IV, MD, MPH as Vice President of Risk Management and Regulatory Affairs. Dr. Wright, a renowned authority on clinical risk assessment, served at the FDA from 1989 to 1997 in its Center for Drug Evaluation and Research.

More News (2 articles) »